Company Overview
Snapshot
Founded in October 2003 by Igor Waysbeyn, HDH Medical operates with 201–500 employees. The company specializes in vascular anastomotic devices, which are designed for sutureless connection of large blood vessels in surgical procedures.
Business overview
HDH Medical develops BYFix, a product line of vascular anastomotic devices complemented by specialized delivery instruments. These devices facilitate sutureless anastomosis of large blood vessels for both laparoscopic and open surgeries. The BYFix technology mechanically connects standard vascular grafts to a patient's blood vessel, ensuring a secure and hermetic anastomosis. It serves the medical devices industry, providing solutions for surgical treatment of conditions such as aortic aneurysms, arterial occlusions, and traumas, with applications in hospitals and for surgeons.
Log in to access full profile ›Company Intelligence Q&A
- What is HDH Medical's primary product?
- HDH Medical's primary product is BYFix, a line of vascular anastomotic devices designed for sutureless connection of large blood vessels during surgical procedures.
- What surgical applications does BYFix support?
- BYFix devices are used as a surgical treatment option for aortic aneurysms, arterial occlusions, and traumas, enabling both laparoscopic and open surgery.
- What is the key benefit of the BYFix technology?
- The BYFix technology enables a sutureless and leak-proof permanent anastomosis in a short timeframe, even for major vessels, offering a minimally invasive alternative to existing techniques.
- Who are the founders of HDH Medical?
- HDH Medical was co-founded by Igor Waysbeyn.
- What is the status of HDH Medical's operations?
- HDH Medical is currently non-active as of February 2017.